Patients’ Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life
Quality of life (QoL) in oncology is an outcome becoming more and more important and relevant to explore. Some studies have demonstrated its prognostic impact in different cancers, such as colorectal, breast, and prostate cancers, but also in hepatocellular carcinoma (HCC). Different tools have been...
Main Authors: | Léa Muzellec, Héloïse Bourien, Julien Edeline |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/1/179 |
Similar Items
-
Current Treatment Landscape for Advanced Hepatocellular Carcinoma: Patient Outcomes and the Impact on Quality of Life
by: Daneng Li, et al.
Published: (2019-06-01) -
Effect of Sarcopenia on Survival and Health-Related Quality of Life in Patients with Hepatocellular Carcinoma after Hepatectomy
by: Jiawei Hu, et al.
Published: (2022-12-01) -
Outcomes and Quality of Life of Systemic Therapy in Advanced Hepatocellular Carcinoma
by: Kehua Zhou, et al.
Published: (2019-06-01) -
Clinical outcomes of rare hepatocellular carcinoma variants compared to pure hepatocellular carcinoma
by: Zakka K, et al.
Published: (2019-07-01) -
Impact of sociodemographic characteristics and drug-related side effects on quality of life of patients with hepatocellular carcinoma receiving sorafenib treatment in Iraqi hospitals
by: Tuqa H. Qasim, et al.
Published: (2023-01-01)